Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trial

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 98cfe9cbe8f015d4-IAD IP: 47.97.18.252 UTC time: 2025-10-11T17:00:21+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

View original article

SEMINARS IN ARTHRITIS AND RHEUMATISM

Like

Share Bookmark

0 0 0 0 0 0 0

More from this channel

Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trial

Comments (0)